Monthly Archives: July 2017

Half-year portfolio review, 2017 edition

With the first half of 2017 behind us it is once again time for the obligatory performance review. As can be seen in the table below my performance was more than satisfactory. While the benchmark eked out a small gain of 3.09% my portfolio returned almost seven times as much. I think by now I can be pretty confident that I have some edge on the market, although it remains to be seen how big it is. In almost every past performance review I have written that I don’t expect that I’ll be able to continue to repeat these returns going forward, and I still think that is the case. But who knows. Maybe, just maybe, I can keep this going for a couple of more years.


* Return in euro’s after transaction costs, dividend withholding taxes and other expenses
** Benchmark is the MSCI ACWI (All Country World Index) net total return index in euro’s

While my results for the first half of 2017 are pretty good I’m actually not that happy about it. I have reflected a bit upon why that is the case, and I think it’s because the good performance is mainly driven by just a couple of lucky outliers while I also had plenty of idea’s this year that didn’t work out or had a lot more potential than what I realized. It’s not very visible in the graph below because most of the variance is hidden in the “special situations” bucket, but Sapec is for example responsible for 795bps of the performance while “undisclosed merger A” added another 454bps. While Sapec was a great idea, the fact that I was able to buy a large position at almost the low of the day after the going private transaction was announced was just luck. That luck is partially being offset by other trades such as Destination Maternity (my biggest loser with a minus 172bps contribution) while “undisclosed merger B and C” subtracted respectively 152bps and 52bps from the result. I’m often attracted to deals where it is hard or impossible to hedge out company specific risk, and as a result I will have to accept some variance.Also very visible is that in the first half of this year my portfolio faced a large headwind from currency movements, mainly caused by the US dollar losing value versus the euro. In previous years this movement was often in the other direction, and I expect that in the long run these gains and losses will roughly even out. The MSCI ACWI benchmark faced a similar currency headwind. It was up 8.95% in local currency, but just 3.09% in euro’s. While I don’t really own any stocks that are part of that index this is one of the reasons why it’s still a useful comparison.

As you can see my portfolio is in broad strokes looking like it usually does with a large allocation to various special situations complemented with a few dozen value stocks. New is the large position labeled “various receivables”. I often participate in special situations that result in a cash outflow while my broker doesn’t recognize the asset that I receive. If the cash outflow is small relative to my portfolio I usually just value these assets at zero, but for larger transactions it would skew my results too much. A large part of these receivables are the tax assets created in the Sapec transaction, but they also contain the DNIB Unwind (liquidation trust) shares at cost and the remaining Primo Water shares held in escrow at market value.

Another change that warrants a mention is that I finally sold my position in Berkshire Hathaway this year. I bought my first shares in 2010, and since then the stock has performed pretty well. At the same time, I don’t expect miracles from it and it’s probably going to perform roughly in line with the US stock market. Since I had more ideas than money on multiple occasions this year I thought it was a good time to say goodbye to this stock.


Author is long everything in the portfolio overview